Rongzhen Jiang

Rongzhen Jiang

Auto-generated profile, based on publicly available information

Rongzhen Jiang

Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
YCYandan Chen
Yandan Chen
SFShuyi Fang
Shuyi Fang
QDQingwei Ding
Qingwei Ding
RJRongzhen Jiang
Rongzhen Jiang
JHJiefeng He
Jiefeng He
BGBin Guo
Bin Guo
The heterogeneity of human hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) under stress conditions such as ex vivo expansion is poorly understood. Here, we report that the frequencies of SCID-repopulating cells were greatly decreased in cord blood (CB) CD34+ HSCs and HPCs upon ex vivo culturing. Transcriptomic analysis and metabolic profiling demonstrated that mitochondrial oxidative stress of human CB HSCs and HPCs notably increased, along with loss of stemness. Limiting dilution analysis revealed that functional human HSCs were enriched in cell populations with low levels of mitochondrial ROS (mitoROS) during ex vivo culturing. Using single-cell RNA-Seq analysis of the mitoROS low cell population, we demonstrated that functional HSCs were substantially enriched in the adhesion GPCR G1–positive (ADGRG1+) population of CD34+CD133+ CB cells upon ex vivo expansion stress. Gene set enrichment analysis revealed that HSC signature genes including MSI2 and MLLT3 were enriched in CD34+CD133+ADGRG1+ CB HSCs. Our study reveals that ADGRG1 enriches for functional human HSCs under oxidative stress during ex vivo culturing, which can be a reliable target for drug screening of agonists of HSC expansion.

1 September 2018 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
QXQinyang Xu
Qinyang Xu
FDFei Du
Fei Du
YZYe Zhang
Ye Zhang
YTYincheng Teng
Yincheng Teng
MTMinfang Tao
Minfang Tao
RJRongzhen Jiang
Rongzhen Jiang

22 December 2006 in Journal of Crystal Growth
Verified
Journal Article
Closed access
ZXZ.L. Xie
Z.L. Xie
RZR. Zhang
R. Zhang
Bin LiuBin Liu
Bin Liu
XJX.L. Ji
X.L. Ji
LLL. Li
L. Li
YZY.D. Zheng
Y.D. Zheng

1 September 2020 in Placenta
Verified
Journal Article
Closed access
FDFei Du
Fei Du
YZYe Zhang
Ye Zhang
QXQinyang Xu
Qinyang Xu
YTYincheng Teng
Yincheng Teng
MTMinfang Tao
Minfang Tao
RJRongzhen Jiang
Rongzhen Jiang

26 September 2014 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
RJRongzhen Jiang
Rongzhen Jiang
YTYincheng Teng
Yincheng Teng
YHYajuan Huang
Yajuan Huang
JGJinghong Gu
Jinghong Gu
LMLi Ma
Li Ma
YZYuedi Zhou
Yuedi Zhou
In women with preeclampsia (PE), endothelial cell (EC) dysfunction can lead to altered secretion of paracrine factors that induce peripheral vasoconstriction and proteinuria. This study examined the hypothesis that PE sera may directly or indirectly, through human umbilical vein ECs (HUVECs), stimulate phospholipase C-γ1-1,4,5-trisphosphate (PLC-γ1-IP3) signaling, thereby increasing protein kinase C-α (PKC-α) activity, collagen I expression and intracellular Ca2+ concentrations ([Ca2+]i) in human umbilical artery smooth muscle cells (HUASMCs). HUASMCs and HUVECs were cocultured with normal or PE sera before PLC-γ1 silencing. Increased PLC-γ1 and IP3 receptor (IP3R) phosphorylation was observed in cocultured HUASMCs stimulated with PE sera (P<0.05). In addition, PE serum significantly increased HUASMC viability and reduced their apoptosis (P<0.05); these effects were abrogated with PLC-γ1 silencing. Compared with normal sera, PE sera increased [Ca2+]i in cocultured HUASMCs (P<0.05), which was inhibited by PLC-γ1 and IP3R silencing. Finally, PE sera-induced PKC-α activity and collagen I expression was inhibited by PLC-γ1 small interfering RNA (siRNA) (P<0.05). These results suggest that vasoactive substances in the PE serum may induce deposition in the extracellular matrix through the activation of PLC-γ1, which may in turn result in thickening and hardening of the placental vascular wall, placental blood supply shortage, fetal hypoxia–ischemia and intrauterine growth retardation or intrauterine fetal death. PE sera increased [Ca2+]i and induced PKC-α activation and collagen I expression in cocultured HUASMCs via the PLC-γ1 pathway.

18 August 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
ZSZicheng Song
Zicheng Song
WLWeiming Luo
Weiming Luo
BHBing Huang
Bing Huang
YCYunfeng Cao
Yunfeng Cao
RJRongzhen Jiang
Rongzhen Jiang
Objective: This study established a model to predict the risk of diabetic retinopathy (DR) with amino acids selected by partial least squares (PLS) method, and evaluated the effect of metformin on the effect of amino acids on DR in the model.Methods: In Jinzhou, Liaoning Province, China, we retrieved 1031 patients with type 2 diabetes (T2D) from the First Affiliated Hospital of Liaoning Medical University. After sorting the amino acids using the PLS method, the top 10 amino acids were included in the model. Multivariate logistic regression was used to analyze the relationship between different amino acids and DR. And then the effects of metformin on amino acids were explored through interaction. Finally, Spearman’s rank correlation analysis was used to analyze the correlation between different amino acids.Results: After sorting by PLS, Gly, Pro, Leu, Lyr, Glu, Phe, Tyr, His, Val and Ser were finally included in the DR risk prediction model. The predictive model after adding amino acids was statistically different from the model that only included traditional risk factors (p=0.001). Metformin had a significant effect on the relationship between DR and 7 amino acids (Gly, Glu, Phe, Tyr, His, Val, Ser, p<0.05), and the population who are not using metformin and have high levels of Glu (OR: 0.44, 95%CI: 0.27-0.71) had an additive protection effect for the occurrence of DR. And the similar results can be seen in high levels of Gly (OR: 0.46, 95%CI: 0.29-0.75), Leu (OR: 0.48, 95%CI: 0.29-0.8), His (OR: 0.46, 95%CI: 0.29-0.75), Phe (OR: 0.24, 95%CI: 0.14-0.42) and Tyr (OR: 0.41, 95%CI: 0.24 -0.68) in population who are not using metformin.Conclusions: We established a prediction model of DR by amino acids and found that the use of metformin reduced the protective effect of amino acids on DR developing, suggesting that amino acids as biomarkers for predicting DR would be affected by metformin use.